Patients with OIS typically present with carotid stenosis of  at least 90% occlusion of the ipsilateral carotid artery, though mild to no stenosis  has also been reported. Other sources of disrupted flow may lead to this  syndrome, such as significant flow limitation of the ophthalmic artery. 
    At presentation, iris neovascularization (NVA) as a result of  limited tissue perfusion is present in approximately two-thirds of cases of  OIS. Even with this predisposition for angle NVA, increased eye pressure is  observed in less than half of eyes as decreased arterial perfusion is believed  to lead to ciliary body hypofunction. 
    Midperipheral retinal hemorrhages are the most common  posterior segment manifestation occurring in ∼80% of patients. Other nonspecific  retinal findings such as cherry-red spot, cotton wool spots, and spontaneous  retinal arterial pulsations may also occur. Fluorescein angiography (FA) may  show prolonged retinal arteriovenous transit time with vascular staining,  delayed/patchy choroidal filling, and retinal capillary nonperfusion.
    Case Presentation
    A 57-year-old woman presented with a 3-month history of  slowly progressive bilateral vision loss. She endorsed light-induced amaurosis  and seeing haloes with no history of eye pain. Her visual acuity was light  perception in both eyes. Her IOPs were 79 and 74 mm Hg in the right and left  eyes, respectively. 
    Findings-  
    Both pupils were mid-dilated and nonreactive. 
    She had mild diffuse corneal microcystic edema in both eyes.  
    Her iris showed no rubeosis. 
    Gonioscopy revealed a universally closed angle bilaterally  without evidence of angle NVA. 
    Her lenses had 2+ nuclear sclerosis bilaterally and she was  not in pupillary block. 
    Her dilated fundus exam showed spontaneous arterial  pulsations , marked cupping of both optic nerves, mild venous tortuosity, and  360 degrees midperipheral intraretinal hemorrhages in both eyes. 
    FA showed an increased arteriovenous transit time of 19 to  20 seconds with sectoral nonperfusion of temporal veins. 
    Macular optical coherence tomography (OCT) was unremarkable.  
    She was started on acetazolamide 500 mg twice a day,  timolol, brinzolamide/brimonidine tartrate, and travoprost in both eyes. CT  angiogram of the neck and brain showed no abnormalities, specifically no  evidence of vascular stenosis.
    Two days later, her IOP had decreased significantly to 9 mm  Hg in the right and 7 mm Hg in the left eye. Her visual acuity improved to  20/80 right eye and 20/250 in the left eye. Her pupils remained minimally  reactive and mid-dilated. At this time she no longer showed spontaneous  arterial pulsations and her corneal microcystic edema resolved. 
    Two months after her initial surgery, her fundoscopic  findings including midperipheral hemorrhages had resolved. 
    Macular OCT showed 1 to 2+ cystoid macular edema, trace  subretinal fluid, and a trace epiretinal membrane in both eyes. 
    Repeat FA showed normal filling, mild cystoid macular edema,  mild peripheral leakage/possible trace ischemia, peripheral microaneurysms, and  optic nerve head staining in both eyes. 
    She was started on topical prednisolone drops 8 times a day  for suspected Irvine -Gass syndrome.
    The report presents an unusual case of bilateral vision loss and fundus  findings consistent with bilateral OIS in the setting of bilateral CACG without  associated angle NVA. The midperipheral hemorrhages argue strongly enough for  OIS that neuroimaging was performed. It is believed that OIS occurs as a result  of chronic insufficient arterial perfusion, most commonly from > 90% carotid  stenosis. 
    Bilateral OIS is usually associated with bilateral carotid  stenosis or systemic inflammatory disorders, such as giant cell arteritis,  moyamoya syndrome, Takayasu arteritis, and increased homocysteine/CRP levels.  While OIS can cause CACG from NVA, this case uniquely described CACG without  NVA causing OIS. There was no evidence of vascular stenosis or systemic  inflammatory disorder and both eyes responded to IOP lowering medications. CACG  itself has not been reported as a cause of OIS.
    "This case showed classic features of OIS and high-IOPs. It  is plausible that central retinal arterial vascular compromise from high-IOPs  secondary to poor aqueous outflow contributed to the appearance of OIS in this  patient. This is consistent with the hypothesis proposed by Song and colleagues  who demonstrate that the sudden increase in IOP in acute angle closure glaucoma  results in decreased choroidal thickness which may be evidence of compression  of the choroidal blood vessels. The compressed choroidal blood vessels may in  turn result in ischemic retinal injury. OIS may initially present with  intraocular hypotension secondary to decreased ciliary body blood supply and  subsequent hypofunction, however, in the setting of bilateral angle closure  with nonfunctioning outflow, high pressures will prevail as they did initially  in this patient."
    The researchers strongly considered central retinal venous occlusion  and diabetic retinopathy in this case. While the patient showed mild  venous tortuosity, she did not have other features consistent with central  retinal venous occlusion including hemorrhages in the posterior pole, swollen  optic nerves or late venous staining on FA. 
    The researchers said, "In conclusion, we report a patient who  developed bilateral OIS in the setting of bilateral CACG with markedly  prolonged, elevated IOP. We postulate that this occurred as a result of  chronically reduced arterial outflow at the level of the central retinal  artery. To our knowledge, this association has not been described previously in  literature."
    Source: Ameay V.  Naravane, Paul W. Mallory, Jess Boysen et al; J Glaucoma Volume 30, Number 5
    DOI: 10.1097/IJG.0000000000001767
 
Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.
NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.